There is a problem with the stock price data. Our supplier is working to solve the issue.
Stockholm Stock Exchange | Mid Cap
3 months
KempenDNBCarnegieRBCRX SecuritiesNordea MarketsDNB Markets

Price Targets For Bioarctic

AnalystPrice TargetDateUpside
Kempen350 SEKNov 27
DNB365 SEKNov 13
Carnegie365 SEKNov 9
RBC450 SEKJul 27
RX Securities400 SEKJun 12
Nordea Markets356 SEKNov -22
DNB Markets250 SEKJul -21

About The Company

BioArctic is a Swedish research intensive biopharma company aimed at developing new treatments that address the causes of disorders that affect the Central Nervous System. These types of treatments are commonly referred to as “disease modifiers”. They affect the underlying disease pathology and can hopefully stop or significantly delay disease progression.